razaxaban has been researched along with pexacerfont in 1 studies
| Studies (razaxaban) | Trials (razaxaban) | Recent Studies (post-2010) (razaxaban) | Studies (pexacerfont) | Trials (pexacerfont) | Recent Studies (post-2010) (pexacerfont) |
|---|---|---|---|---|---|
| 20 | 0 | 2 | 13 | 5 | 8 |
| Protein | Taxonomy | razaxaban (IC50) | pexacerfont (IC50) |
|---|---|---|---|
| Substance-K receptor | Homo sapiens (human) | 4.9 | |
| Corticotropin-releasing factor receptor 1 | Homo sapiens (human) | 0.1169 | |
| Corticotropin-releasing factor receptor 1 | Rattus norvegicus (Norway rat) | 0.0368 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badawy, SI; LaMarche, K; Narang, AS; Subramanian, G; Varia, SA | 1 |
1 other study(ies) available for razaxaban and pexacerfont
| Article | Year |
|---|---|
Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation.
Topics: Alanine; Drug Compounding; Isoxazoles; Particle Size; Porosity; Powders; Pyrazoles; Quality Control; Solubility; Tablets; Technology, Pharmaceutical; Triazines; Water | 2012 |